Back to results
US 2026/0061024 A1Published application
Nasal delivery of apigenin and linear peptide inhibitors of mitochondrial fission
AssigneeNeuroTher, LLC
InventorsBhanu Pratap Jena, Guillermo G. Marmol, Won Jin Cho
Life of this patent
Estimating the term…
Abstract
Disclosed are multi-peptide compositions and/or methods of use of the multi-peptide compositions for subjects suffering from or at risk for a neural disease. Pharmaceutically acceptable embodiments administered subjects may treat or prevent the neural disease. In certain embodiments, a flavonoid compound is administered in conjunction with a peptide. In still other embodiments, a porosome complex is administered with the peptide and/or with the flavonoid compound.
Claims14
A composition comprising:
- a flavonoid;
- and,
- at least one linear peptide associated with mitochondrial fission;
- wherein the composition is pharmaceutically acceptable for administration to a subject.
1 more element
A composition, comprising:
- apigenin;
- and,
- at least one DA1 based linear peptide.
Dependencies are inferred from the claim text.